Cargando…

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

PURPOSE: Immunotherapy is one of the treatment strategies for breast cancer, the most common cancer in women worldwide. In this approach, the patient's immune system is stimulated to attack microscopic tumors and control metastasis. Here, we used interferon γ-induced protein 10 (IP-10), which i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taslimi, Yasaman, Zahedifard, Farnaz, Habibzadeh, Sima, Taheri, Tahereh, Abbaspour, Hossain, Sadeghipour, Alireza, Mohit, Elham, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822105/ https://www.ncbi.nlm.nih.gov/pubmed/27066094 http://dx.doi.org/10.4048/jbc.2016.19.1.34

Ejemplares similares

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022)

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
por: Taslimi, Yasaman, et al.
Publicado: (2017)

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
por: Doroud, Delaram, et al.
Publicado: (2011)

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
por: Badirzadeh, Alireza, et al.
Publicado: (2017)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum
por: Habibzadeh, Sima, et al.
Publicado: (2021)

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Correction: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L. tropica
por: Taslimi, Yasaman, et al.
Publicado: (2023)

Post-Genomics and Vaccine Improvement for Leishmania
por: Seyed, Negar, et al.
Publicado: (2016)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014)

Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells
por: SADEGHI, Somaye, et al.
Publicado: (2016)

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice
por: Davarpanah, Elaheh, et al.
Publicado: (2020)

In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
por: Seyed, Negar, et al.
Publicado: (2011)

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
por: Sadeghi, Somayeh, et al.
Publicado: (2015)

Improvement of different vaccine delivery systems for cancer therapy
por: Bolhassani, Azam, et al.
Publicado: (2011)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Enhancement of potent immune responses to HPV16 E7 antigen by using different vaccine modalities
por: Bolhassani, Azam, et al.
Publicado: (2011)

Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
por: Seyed, Negar, et al.
Publicado: (2018)

CD8(+) T Cells in Leishmania Infections: Friends or Foes?
por: Stäger, Simona, et al.
Publicado: (2012)

Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice
por: Pishraft Sabet, Leila, et al.
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

DNA Immunization as an Efficient Strategy for Vaccination
por: Bolhassani, Azam, et al.
Publicado: (2009)

Effect of Extent of White Spot Lesions on the Esthetic Outcome after Treatment by the Resin Infiltration Technique: A Clinical Trial
por: Gholami, Sima, et al.
Publicado: (2023)

Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
por: Seyed, Negar, et al.
Publicado: (2014)

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report
por: MORTAZAVI, Hossein, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_njcrgip8ad9tqnjik2b2dtb442